After a decade of stalled progress, a flurry of new studies is sparking hope in the fight against the deadly skin cancer melanoma. Studies by Keith T. Flaherty, HMS associate professor of medicine at Massachusetts General Hospital; F. Stephen Hodi, HMS associate professor of medicine at the Dana-Farber Cancer Institute; and David McDermott, director of the biologic therapy program at Beth Israel Deaconess Medical Center, are featured.
